ADVANCED CANCERS
Clinical trials for ADVANCED CANCERS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CANCERS trials appear
Sign up with your email to follow new studies for ADVANCED CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody injection targets Hard-to-Treat lung cancer in early trial
Disease control Recruiting nowThis early-stage study tests a new drug called TQB2922, given as a shot under the skin, in 42 people with advanced non-small cell lung cancer that has not responded to standard treatments. The drug is a bispecific antibody designed to block two cancer-related proteins (EGFR and c…
Matched conditions: ADVANCED CANCERS
Phase: PHASE1 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Magic mushroom compound tested for cancer pain that opioids Can't touch
Symptom relief Recruiting nowThis study tests whether psilocybin, the active ingredient in magic mushrooms, can help relieve severe pain in people with advanced cancer when opioids don't work. Fifteen participants will receive psilocybin capsules along with therapy sessions. The goal is to see if this approa…
Matched conditions: ADVANCED CANCERS
Phase: PHASE2 • Sponsor: Yvan Beaussant, MD, MSci • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Mapping cancer DNA to match patients with targeted drugs
Knowledge-focused Recruiting nowThis study aims to understand advanced cancers by analyzing their complete genetic code. Researchers will take biopsies and blood samples from 5,000 participants to identify genetic 'drivers' of their cancer. The goal is to see if this information helps doctors choose more person…
Matched conditions: ADVANCED CANCERS
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC